Geneva spinout Amal Therapeutics moves on with the development of its potential colorectal cancer therapy as it raises $3.1m in series A funding.

Unilever Ventures was among the investors as UK-based location-based adtech company Blis raised capital that will support an expansion into the US.

Boehringer Ingelheim returned to reinvest in the in-vitro diagnostics technology company, taking its overall funding to more than $50m as it gears up to release its product.

The car manufacturer has launched an incubator called InMotion that will focus on app development and services around on-demand travel.

Forbion Capital Partners has closed its third main fund at $208m, attracting commitments from Charles River Laboratories, Knight Therapeutics and unnamed insurance providers.

Robert Bosch's corporate venturing unit now has roughly $480m under management, launching its third fund and disclosing its latest investment, in irrigation technology developer CropX.

Statoil's newly formed $200m cleaner energy-focused fund will look to build up a portfolio of 15 to 25 companies in the next four to seven years, according to SEV managing director Gareth Burns.

Scalable Capital, a digital wealth manager based on investors' appetite for risk, has added Tengelmann to its investor base in a $7.9m round that took its overall funding past $12m.